ACR 2020: Prolonged QTc Interval Not a Concern With Use of Hydroxychloroquine for Rheumatic Disease
Findings in COVID-19 patients who received hydroxychloroquine may be a reflection of the critical nature of their condition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.